Clinical Trial Update: A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 1/2 study of ERAS-007 in patients with advanced gastrointestinal malignancies, specifically metastati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• ERAS-007

Snippet

Sponsor: Erasca, Inc. | Conditions: Metastatic Colorectal Cancer, Metastatic Pancreatic Ductal Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED